ALG13 Gene Glycosylation Disorder Type 1S Genetic Test
Test Name: ALG13 Gene Glycosylation Disorder Type 1S Genetic Test
Components: DNA Labs UAE offers the ALG13 Gene Glycosylation Disorder Type 1S Genetic Test at a price of 4400.0 AED.
Sample Condition: The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery: The test results will be delivered within 3 to 4 weeks.
Method: The ALG13 Gene Glycosylation Disorder Type 1S Genetic Test utilizes NGS (Next-Generation Sequencing) technology.
Test Type: The test is classified under Metabolic Disorders.
Doctor: The test can be ordered by a General Physician.
Test Department: The test is conducted by the Genetics department.
Pre Test Information: It is recommended to provide the clinical history of the patient who is undergoing the ALG13 Gene Glycosylation Disorder Type 1S NGS Genetic DNA Test. A Genetic Counselling session is also advised to draw a pedigree chart of family members affected by Glycosylation Disorder Type 1S.
Test Details
ALG13 gene glycosylation disorder type 1S is a rare genetic disorder that affects the glycosylation process in the body. Glycosylation is a process in which sugar molecules are attached to proteins or lipids, playing a crucial role in various cellular functions.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ALG13 gene glycosylation disorder type 1S, NGS genetic testing can be used to identify mutations or variations in the ALG13 gene, which is responsible for this specific disorder.
The NGS genetic test for ALG13 gene glycosylation disorder type 1S involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the ALG13 gene. These variations or mutations can help in confirming a diagnosis of ALG13 gene glycosylation disorder type 1S.
The results of the NGS genetic test can provide valuable information for healthcare professionals in managing the condition. It can help in understanding the underlying genetic cause of the disorder, predicting the severity of symptoms, and guiding treatment decisions.
It’s important to note that NGS genetic testing is typically performed by specialized laboratories and requires a healthcare professional’s order. Genetic counseling is often recommended before and after testing to discuss the implications of the results and provide support to individuals and families affected by ALG13 gene glycosylation disorder type 1S.
| Test Name | ALG13 Gene Glycosylation disorder type 1S Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ALG13 Gene Glycosylation disorder type 1S NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1S |
| Test Details |
ALG13 gene glycosylation disorder type 1S is a rare genetic disorder that affects the glycosylation process in the body. Glycosylation is a process in which sugar molecules are attached to proteins or lipids, playing a crucial role in various cellular functions. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ALG13 gene glycosylation disorder type 1S, NGS genetic testing can be used to identify mutations or variations in the ALG13 gene, which is responsible for this specific disorder. The NGS genetic test for ALG13 gene glycosylation disorder type 1S involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the ALG13 gene. These variations or mutations can help in confirming a diagnosis of ALG13 gene glycosylation disorder type 1S. The results of the NGS genetic test can provide valuable information for healthcare professionals in managing the condition. It can help in understanding the underlying genetic cause of the disorder, predicting the severity of symptoms, and guiding treatment decisions. It’s important to note that NGS genetic testing is typically performed by specialized laboratories and requires a healthcare professional’s order. Genetic counseling is often recommended before and after testing to discuss the implications of the results and provide support to individuals and families affected by ALG13 gene glycosylation disorder type 1S. |
